share_log

HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $200 Price Target

Moomoo 24/7 ·  Apr 22 13:48

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $200 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment